Skip to main content
. 2020 Aug 19;10(51):30620–30623. doi: 10.1039/d0ra06404a

In vitro antitumor activities of the target compounds (IC50, nM).

Compounds IC50 (nM)
Hep3B
3a N.D.a
3b N.D.
3f N.D.
3g N.D.
3h >10 000
3i >10 000
3j 4986.0
3k >10 000
3l N.D.
3m/3m′ N.D.
3n/3n′ N.D.
3o/3o′ N.D.
3p/3p′ N.D.
4 601.7
Infigratinib 224.2
a

Not determined.